ENTITY

Akero Therapeutics (AKRO US)

2
Analysis
Health Care • United States
Akero Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops medicines and therapies for metabolic diseases by restoring metabolic balance. Akero Therapeutics serves patients and customers in the States of Massachusetts and California.
more
Exchange Announcement • 09 Dec 2025 22:12

Current Report (Form 8-K | Period ending 2025-12-09)

Exchange Announcement • 03 Dec 2025 23:42

Current Report (Form 8-K | Period ending 2025-12-02)

Exchange Announcement • 08 Nov 2025 02:43

DEFM14A | Definitive proxy statement relating to merger or acquisition

Exchange Announcement • 07 Nov 2025 08:00

Quarterly Report (Form 10-Q | Period ending 2025-09-30)

Exchange Announcement • 10 Oct 2025 04:31

Current Report (Form 8-K | Period ending 2025-10-08)

x